<DOC>
	<DOCNO>NCT00557843</DOCNO>
	<brief_summary>The primary objective evaluate influence continuous local anesthetic infiltration tissue oxygenation surgical procedure require abdominal surgery major predictor wound healing .</brief_summary>
	<brief_title>Continuous Bupivacaine Infusion Following Colonic Surgery</brief_title>
	<detailed_description>Patients undergo abdominal surgery randomize one two group . Group 1 : Wound perfusion bupivacaine , plus patient control analgesia ( PCA ) Group 2 : Wound perfusion placebo solution ( isotonic saline ) plus patient control analgesia ( PCA ) All patient premedicated IV midazolam 5 mg. On arrival operating room , fluid bolus 10 ml/kg/h administer induction anesthesia . Those randomized local wound perfusion receive local anesthetic placebo via ON-Q pain management system . At end surgery catheter position subcutaneous layer wound , leave via separate stab incision . The wound closure complete . A load dose local anesthetic solution , 20 ml lidocaine 1 % plus 20 ml bupivacaine 0.5 % , , amount placebo inject wound patient leave operate room . Thereafter bupivacaine 0.5 % alone placebo inject continuously wound flow rate 2 ml/h 24 hour . Subcutaneous oxygen tension ( PsqO2 ) evaluate intraoperatively polygraphic-type tissue oxygen sensor position within subcutaneous , saline fill SilasticÂ® tonometer insert patient ' upper arm induction anesthesia . Postoperative pain relief maintain patient-controlled analgesia ( PCA ) morphine ( 2mg bolus , 6-minute lock-out ) local anesthetic wound perfusion . Patients give supplemental oxygen via face mask rate 2 L/min . Additional oxygen give necessary maintain oxygen saturation &gt; 95 % . An observer blind group assignment perform postoperative evaluation . Patient chart review undertaken screen evidence surgical wound infection . The presence infection determine review attend surgeon 's documentation patient 's chart .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>1 . 1880 year age . 2 . The patient provide write informed consent . 3 . The patient schedule abdominal surgery . 4 . The patient ASA I , II , III . 5 . The patient understands explanation protocol . 1 . Patients age &lt; 18 &gt; 80 year . 2 . History diabetes mellitus . 3 . History congestive heart failure . 4 . History peripheral vascular disease . 5 . History smoking . 6 . History Dysautonomia . 7 . History thyroid disease . 8 . Susceptibility malignant hyperthermia . 9 . History morbid obesity . 10 . History fever 11 . History infection . 12 . Contraindication placement arterial line ; e.g. , Raynaud 's disease . 13 . The patient decline participation . 14 . Any patient investigator feel candidate study . 15 . Any patient history know alcohol , analgesic , narcotic substance abuse within two year screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Bupivacaine</keyword>
	<keyword>Colon</keyword>
	<keyword>Surgery</keyword>
	<keyword>Oxygenation</keyword>
</DOC>